Skip to main content

and
  1. No Access

    Article

    Targeted therapy in hormone refractory prostate cancer

    Despite recent progress in the treatment of hormone refractory prostate cancer—with a survival advantage seen with docetaxel chemotherapy—there remains a need for further improvements in this important patient...

    S. Burbridge, S. Chowdhury, P. G. Harper in Targeted Oncology (2007)

  2. Article

    Open Access

    Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse

    Differentiation of active disease from fibrosis/mature teratoma in patients with residual masses or identifying of sites of recurrence in patients with raised markers following treatment of their testicular ca...

    S F Hain, M J O'Doherty, A R Timothy, M D Leslie, P G Harper in British Journal of Cancer (2000)

  3. No Access

    Article

    Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry

    We studied the variability in doxorubicin pharmacokinetics in 27 patients, all of whom had normal liver biochemistry tests. Blood samples were collected after the first cycle of single-agent doxorubicin given ...

    N. A. Dobbs, C. J. Twelves, H. Gillies, C. A. James in Cancer Chemotherapy and Pharmacology (1995)

  4. No Access

    Article

    Comparative pharmacokinetics of doxorubicin given by three different schedules with equal dose intensity in patients with breast cancer

    The pharmacokinetics of doxorubicin given according to three different schedules with a similar dosetime intensity have been studied and compared in 16 women with metastatic breast cancer. Six patients were tr...

    C. J. Twelves, N. A. Dobbs, M. Aldhous in Cancer Chemotherapy and Pharmacology (1991)

  5. No Access

    Article

    Sequential chemotherapy in good-prognosis patients with small-cell lung cancer

    A sequential combination chemotherapy regimen was evaluated in 23 patients with small-cell lung cancer (16, limited disease; 7, extensive disease). All patients had an Eastern Cooperative Oncology Group (ECOG)...

    C. J. Twelves, J. Goldman, C. M. Ash, R. L. Souhami in Cancer Chemotherapy and Pharmacology (1991)

  6. No Access

    Article

    A phase II study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervix

    A total of 44 women received a combination of ifosfamide (1.5 g/m2 daily x5) and cisplatin (50 mg/m2 on day 1 only) as first-line chemotherapy for recurrent or metastatic carcinoma of the cervix. In all, 12/42 (3...

    R. E. Coleman, J. M. Clarke, M. L. Slevin in Cancer Chemotherapy and Pharmacology (1990)

  7. No Access

    Article

    Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancer

    Since 1980, 75 patients with small-cell lung cancer (SCLC) have been entered into four consecutive studies of high-dose chemotherapy using autologous bone marrow transplantation (ABMT) to assist haematological...

    R. L. Souhami, H. T. Hajichristou, D. W. Miles in Cancer Chemotherapy and Pharmacology (1989)

  8. No Access

    Article

    Effect of cancer chemotherapy on dapsone N-acetylation in man

    The effect of cancer chemotherapy on dapsone (DDS) N-acetylation was explored in 28 patients with various malignancies. There was a significant (P=0.01) increase in plasma monoacetydapsone/dapsone (MADDS/DDS) rat...

    P. A. Philip, P. G. Harper, H. J. Rogers in Cancer Chemotherapy and Pharmacology (1989)

  9. No Access

    Article

    A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix

    Forty-one patients with advanced progressing carcinoma of the cervix were treated with ifosfamide 1.5 g/m2 daily in a 30-min infusion for 5 days every 3 weeks. The overall response rate (complete + partial) was 1...

    R. E. Coleman, P. G. Harper, C. Gallagher in Cancer Chemotherapy and Pharmacology (1986)

  10. No Access

    Article

    Very high dose chemotherapy with autologous bone marrow rescue in adult patients with resistant relapsed lymphoma

    Seventeen patients with advanced lymphoma were treated with high-dose chemotherapy with autologous bone marrow rescue. In 11 patients with non-Hodgkin's lymphoma (NHL) there were 2 complete remissions (CRs) an...

    C. C. Anderson, A. H. Goldstone, R. L. Souhami in Cancer Chemotherapy and Pharmacology (1986)

  11. No Access

    Chapter

    Intensive Chemotherapy with Autologous Bone Marrow Transplantation in Small Cell Carcinoma of the Lung

    In spite of improvements in response rate with combination chemotherapy, median survival is poor in both limited and extensive disease. The best figures for median survival are 18 months in limited disease and...

    P. G. Harper, R. L. Souhami in Small Cell Lung Cancer (1985)

  12. No Access

    Chapter

    Lung Cancer: Future Prospects

    Since lung cancer is predominantly caused by smoking, future trends in the disease will be largely determined by what happens to smoking habits over the next few decades and this will be discussed in the next ...

    D. M. Geddes, S. G. Spiro, J. S. Tobias, R. L. Souhami, P. G. Harper in Lung Cancer (1984)

  13. No Access

    Article

    Decreased plasma half-life of cyclophosphamide during repeated high-dose administration

    Cyclophosphamide was given as IV doses of 50 mg/kg/day on each of four successive days as treatment for ovarian and lung cancer. Blood samples were taken at regular intervals and analysed for cyclophosphamide ...

    M. I. Graham, I. C. Shaw, R. L. Souhami, B. Sidau in Cancer Chemotherapy and Pharmacology (1983)

  14. No Access

    Article

    High-dose cyclophosphamide with autologous marrow transplantation as initial treatment of small cell carcinoma of the bronchus

    Sixteen patients with untreated small cell carcinoma of the bronchus received cyclophosphamide in a total dose of 160–200 mg/kg. Autologous marrow transplantation was used to minimise the period of hypoplasia ...

    R. L. Souhami, P. G. Harper, D. Linch, C. Trask in Cancer Chemotherapy and Pharmacology (1982)

  15. No Access

    Article

    Epipodophyllotoxin (VP16-213) in small cell carcinoma of the bronchus resistant to initial combination chemotherapy

    Thirty-eight patients with small cell carcinoma of the bronchus resistant to initial chemotherapy with cyclophosphamide methotrexate and CCNU, were treated with VP16-213 alone in a dose of 120 mg/m2 i.v. on days ...

    P. G. Harper, M. B. Dally, D. M. Geddes in Cancer Chemotherapy and Pharmacology (1982)

  16. No Access

    Chapter and Conference Paper

    An Anharmonic Model for Molecular Photo-Excitation

    Photo-excitation of polyatomic molecules occurs when sufficient laser energy is accepted by the near resonant dipole mode and transferred to the anharmonic dissociation mode. The theoretical problem then centr...

    P. G. Harper in Laser-Induced Processes in Molecules (1979)

  17. Article

    Authoritative text on quantum electronics

    Quantum Electronics: A Treatise.

    P. G. Harper in Nature (1976)

  18. No Access

    Article

    Superconducting flux structure probed with positive muons

    P. G. Harper in Nature (1974)

  19. No Access

    Chapter and Conference Paper

    Peierls Instability in the Layer Semiconductor MoS2?

    The electrical conductivity of pure crystals of 2H MoS2 has been measured at pressures up to 36 k bars. A two fold increase is observed between zero and 7 k bars. Theory is presented to relate this behaviour to a...

    P. G. Harper, S. H. El-Mahalawy, B. L. Evans in Proceedings of the Twelfth International C… (1974)

  20. No Access

    Chapter

    Light Absorption by Electrons in Polar Crystals in a Strong Magnetic Field

    An optical phonon structure is proposed for cyclotron absorption in polar crystals at high magnetic fields. This is due to an induced modulation of the optical dipole by the electron phonon interaction. The th...

    P. G. Harper in Cooperative Phenomena (1973)